151P Maintenance Therapy using Tyrosine Kinase Inhibitor (erlotinib) or Pemetrexed in metastatic/locally advanced in EGFR Mutation-Negative Lung Cancer: Comparison of Results
In Journal of Thoracic Oncology
By: Gupta K.
Contributor(s): Joshi A | Noronha V | Parthiban SK | Patil V | Janu A | Kaushal R | Prabhash K.
Material type:
Item type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
![]() |
Tata Memorial Hospital | Available | AR18934 |
No Abstract
There are no comments for this item.